Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.02
BIOS's Cash to Debt is ranked lower than
93% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. BIOS: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
BIOS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.53 Max: No Debt
Current: 0.02
Equity to Asset -0.18
BIOS's Equity to Asset is ranked lower than
96% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. BIOS: -0.18 )
Ranked among companies with meaningful Equity to Asset only.
BIOS' s Equity to Asset Range Over the Past 10 Years
Min: -0.18  Med: 0.43 Max: 0.75
Current: -0.18
-0.18
0.75
F-Score: 3
Z-Score: -1.41
M-Score: -5.11
WACC vs ROIC
7.52%
-64.96%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -28.33
BIOS's Operating margin (%) is ranked lower than
95% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 7.16 vs. BIOS: -28.33 )
Ranked among companies with meaningful Operating margin (%) only.
BIOS' s Operating margin (%) Range Over the Past 10 Years
Min: -9.26  Med: -0.05 Max: 2.06
Current: -28.33
-9.26
2.06
Net-margin (%) -29.20
BIOS's Net-margin (%) is ranked lower than
95% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. BIOS: -29.20 )
Ranked among companies with meaningful Net-margin (%) only.
BIOS' s Net-margin (%) Range Over the Past 10 Years
Min: -14.99  Med: -2.77 Max: 9.77
Current: -29.2
-14.99
9.77
ROA (%) -47.70
BIOS's ROA (%) is ranked lower than
97% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 3.77 vs. BIOS: -47.70 )
Ranked among companies with meaningful ROA (%) only.
BIOS' s ROA (%) Range Over the Past 10 Years
Min: -27.23  Med: -9.33 Max: 20.26
Current: -47.7
-27.23
20.26
ROC (Joel Greenblatt) (%) -341.11
BIOS's ROC (Joel Greenblatt) (%) is ranked lower than
97% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 18.36 vs. BIOS: -341.11 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
BIOS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -83.89  Med: -6.75 Max: 23.24
Current: -341.11
-83.89
23.24
Revenue Growth (3Y)(%) -24.20
BIOS's Revenue Growth (3Y)(%) is ranked lower than
93% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. BIOS: -24.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
BIOS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -29.4  Med: 2.10 Max: 12.5
Current: -24.2
-29.4
12.5
» BIOS's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-10)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

BIOS Guru Trades in Q2 2015

Jim Simons 295,350 sh (New)
Diamond Hill Capital 2,623,564 sh (New)
Pioneer Investments 280,320 sh (unchged)
Mario Gabelli 1,131,471 sh (-13.03%)
Ron Baron 252,500 sh (-32.21%)
» More
Q3 2015

BIOS Guru Trades in Q3 2015

Diamond Hill Capital 2,980,719 sh (+13.61%)
Pioneer Investments 280,320 sh (unchged)
Jim Simons Sold Out
Ron Baron Sold Out
Mario Gabelli 852,600 sh (-24.65%)
» More
Q4 2015

BIOS Guru Trades in Q4 2015

Jim Simons 102,220 sh (New)
Diamond Hill Capital 3,055,476 sh (+2.51%)
Mario Gabelli 864,850 sh (+1.44%)
Pioneer Investments 280,320 sh (unchged)
» More
Q1 2016

BIOS Guru Trades in Q1 2016

Diamond Hill Capital 3,568,829 sh (+16.80%)
Pioneer Investments 280,320 sh (unchged)
Jim Simons Sold Out
Mario Gabelli 839,352 sh (-2.95%)
» More
» Details

Insider Trades

Latest Guru Trades with BIOS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:AMEX:HLTH, NYSE:CCM, NAS:USMD, OTCPK:CMBGF, NAS:ADUS, OTCPK:FDNH, OTCPK:CATS, OTCPK:CVHIF, NAS:JYNT, OTCPK:AMEH, OTCPK:CCEL, OTCPK:AGHEF, OTCPK:FCHS, OTCPK:BNKL, OTCPK:BRRZY, AMEX:AMS, AMEX:HH, OTCPK:SPIN, OTCPK:WNDM, OTCPK:PFHO » details
Traded in other countries:MM6.Germany,
BioScrip Inc provides home infusion & other home healthcare services to patients, physicians, hospitals, healthcare payors & pharmaceutical manufacturers to provide clinical management solutions & delivers cost-effective access to medications.

BioScrip Inc, formerly known as MIM Corporation, was incorporated in Delaware in 1996. The Company provides home infusion and other home healthcare services to patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and delivers cost-effective access to prescription medications and home health services. Its services are provided in coordination with, and under the direction of the patient's physicians. The sales and marketing efforts are focused on payors, healthcare systems and physician prescribers and are driven by dedicated managed care and physician sales teams as well as home health care consultants. PBM Services has over 100 relationships with PBM clients, including Medicaid MCOs, employers, TPAs, workers compensation providers and discount card marketers. The Company undertakes direct sales methods to promote the discount card program and add new marketing organizations. The Company owns trademarks, trade names and service marks including BioScrip, BioScrip Infusion Services, BioScrip Medical Supply Services, BioScrip PBM Services, BioScrip Pharmacy Services, Applied Health Care, CarePoint Partners, Critical Homecare Solutions, Deaconess HomeCare, Deaconess Hospice, among others. The Company's competitors within the home infusion market include Walgreen Co., including OptionCare and Critical Care Systems; CVS Caremark Corp., through its recent acquisition of the Coram infusion business; Express Scripts Holding Company through its subsidiary Accredo Health Group; and various regional and local providers of alternate site healthcare services such as hospitals, local home health agencies, and other local providers. In Home Health Services, the Company competes with Gentiva Health Services, Inc., Almost Family, Inc., Amedisys, Inc., LHC Group, Inc., among others. In PBM and Discount Card Services, the competitors include Express Scripts, Inc., Catamaran Corp., and CVS/Caremark Corp.

Ratios

vs
industry
vs
history
P/S 0.17
BIOS's P/S is ranked higher than
96% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. BIOS: 0.17 )
Ranked among companies with meaningful P/S only.
BIOS' s P/S Range Over the Past 10 Years
Min: 0.04  Med: 0.20 Max: 1.31
Current: 0.17
0.04
1.31
Current Ratio 1.17
BIOS's Current Ratio is ranked lower than
56% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. BIOS: 1.17 )
Ranked among companies with meaningful Current Ratio only.
BIOS' s Current Ratio Range Over the Past 10 Years
Min: 0.86  Med: 1.35 Max: 2.76
Current: 1.17
0.86
2.76
Quick Ratio 0.96
BIOS's Quick Ratio is ranked lower than
63% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. BIOS: 0.96 )
Ranked among companies with meaningful Quick Ratio only.
BIOS' s Quick Ratio Range Over the Past 10 Years
Min: 0.79  Med: 1.16 Max: 2.5
Current: 0.96
0.79
2.5
Days Inventory 18.43
BIOS's Days Inventory is ranked lower than
51% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 18.01 vs. BIOS: 18.43 )
Ranked among companies with meaningful Days Inventory only.
BIOS' s Days Inventory Range Over the Past 10 Years
Min: 7.2  Med: 14.99 Max: 37.85
Current: 18.43
7.2
37.85
Days Sales Outstanding 25.71
BIOS's Days Sales Outstanding is ranked higher than
74% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 42.78 vs. BIOS: 25.71 )
Ranked among companies with meaningful Days Sales Outstanding only.
BIOS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.3  Med: 45.15 Max: 74.62
Current: 25.71
39.3
74.62
Days Payable 26.70
BIOS's Days Payable is ranked lower than
69% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. BIOS: 26.70 )
Ranked among companies with meaningful Days Payable only.
BIOS' s Days Payable Range Over the Past 10 Years
Min: 15.24  Med: 21.85 Max: 45.45
Current: 26.7
15.24
45.45

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.86
BIOS's Price/Median PS Value is ranked higher than
69% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. BIOS: 0.86 )
Ranked among companies with meaningful Price/Median PS Value only.
BIOS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.25  Med: 1.08 Max: 6.52
Current: 0.86
0.25
6.52
Earnings Yield (Greenblatt) (%) -48.30
BIOS's Earnings Yield (Greenblatt) (%) is ranked lower than
96% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. BIOS: -48.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
BIOS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 2.50 Max: 9.5
Current: -48.3
0.1
9.5
Forward Rate of Return (Yacktman) (%) -12.18
BIOS's Forward Rate of Return (Yacktman) (%) is ranked lower than
87% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 10.08 vs. BIOS: -12.18 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
BIOS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -86.4  Med: -1.85 Max: 6
Current: -12.18
-86.4
6

More Statistics

Revenue (TTM) (Mil) $991.8
EPS (TTM) $ -4.37
Beta0.41
Short Percentage of Float25.87%
52-Week Range $1.19 - 3.93
Shares Outstanding (Mil)68.78

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 921 939 1,010
EPS ($) -0.15 0.13 0.22
EPS w/o NRI ($) -0.15 0.13 0.22
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
» More Articles for NAS:BIOS

Headlines

Articles On GuruFocus.com
5-year lows: Elizabeth Arden Inc, Systemax Inc, BioScrip Inc, and Thompson Creek Metals Co Inc. May 26 2015 
5-year lows: Resource Capital Corp, Dynex Capital Inc, BioScrip Inc, and Kemet Corp. May 10 2015 
Two Gurus Hold Stakes in Embattled BioScrip Apr 07 2015 
A Look at Mario Gabelli's Latest Stake Increases Apr 01 2015 
Mario Gabelli Ups Stake in BioScript, But Value of Stock Declines Mar 18 2015 
A Look at Mario Gabelli's New Added Positions Feb 04 2015 
Mario Gabelli Boosts BioScrip Inc. Position Oct 28 2014 
Soros and Gabelli Top Guru Real Time Picks of the Week Aug 08 2014 
Gurus' Real Time Stock Picks of the Week May 09 2014 
Morning Coffee: Real-Time Picks May 07 2014 

More From Other Websites
Coliseum Capital Adds To Its Stake In BioScrip Inc (BIOS) Jun 26 2016
BIOSCRIP, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 22 2016
BioScrip Completes Public Offering of Common Stock Jun 22 2016
BioScrip Completes Public Offering of Common Stock Jun 22 2016
High-Flying BioScrip Inc. (BIOS) Registers Insider Buying; Amazon Supplier and Funeral Services... Jun 21 2016
Coverage of Top Gainers Elizabeth Arden Vista Gold BioScrip and Lumber Liquidator Holdings Jun 20 2016
BIOSCRIP, INC. Files SEC form 8-K/A, Other Events Jun 20 2016
BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Jun 17 2016
BioScrip Prices Underwritten Offering of Common Stock Jun 16 2016
BioScrip Prices Underwritten Offering of Common Stock Jun 16 2016
BioScrip and Home Solutions Enter Into Amended Agreement Jun 16 2016
BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Jun 16 2016
BioScrip and Home Solutions Enter Into Amended Agreement Jun 16 2016
BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to... Jun 14 2016
Monday Headlines Being Dominated by Facebook, Pfizer, Symantec, More Jun 13 2016
New Denver medical company makes big purchase Jun 13 2016
BioScrip (BIOS): Soft Revenue Outlook & Weak Margins Linger Jun 13 2016
BioScrip Buys HS Infusion Holdings Jun 13 2016
BIOSCRIP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors... Jun 13 2016
BioScrip Announces Transformative Acquisition of Home Solutions That Will Enhance Focus as Home... Jun 13 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)